Evidence map›Paper›PMID 40032663›Full record

ArticleSurgical endoscopy2025

Enhanced prediction of 5-year postoperative recurrence in hepatocellular carcinoma by incorporating LASSO regression and random forest models.

Bing-Bing Su, Chao-Jie Zhu, Jun Cao, Rui Peng, Dao-Yuan Tu, Guo-Qing Jiang, Sheng-Jie Jin, Qian Wang, Chi Zhang, Dou-Sheng Bai

Abstract read
PubMed Publisher
In one paragraph

Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Bing-Bing Su *Department of Hepatobiliary Surgery, Northern Jiangsu People'S Hospital Affiliated to Yangzhou University, Yangzhou, China.
Chao-Jie Zhu *Department of Hepatobiliary Surgery, Northern Jiangsu People'S Hospital Affiliated to Yangzhou University, Yangzhou, China.
Jun Cao *Department of Hepatobiliary Surgery, Northern Jiangsu People'S Hospital Affiliated to Yangzhou University, Yangzhou, China.
Rui Peng *Department of Hepatobiliary Surgery, Northern Jiangsu People'S Hospital Affiliated to Yangzhou University, Yangzhou, China.
Dao-Yuan TuDepartment of Hepatobiliary Surgery, Northern Jiangsu People'S Hospital Affiliated to Yangzhou University, Yangzhou, China.
Guo-Qing JiangDepartment of Hepatobiliary Surgery, Northern Jiangsu People'S Hospital Affiliated to Yangzhou University, Yangzhou, China.
Sheng-Jie JinDepartment of Hepatobiliary Surgery, Northern Jiangsu People'S Hospital Affiliated to Yangzhou University, Yangzhou, China.
Qian WangDepartment of Hepatobiliary Surgery, Northern Jiangsu People'S Hospital Affiliated to Yangzhou University, Yangzhou, China.
Chi ZhangDepartment of Hepatobiliary Surgery, Northern Jiangsu People'S Hospital Affiliated to Yangzhou University, Yangzhou, China.
Dou-Sheng BaiDepartment of Hepatobiliary Surgery, Northern Jiangsu People'S Hospital Affiliated to Yangzhou University, Yangzhou, China. drbaidousheng@yzu.edu.cn.ORCID http://orcid.org/0000-0001-8032-7959

Funding

National Natural Science Foundation of China 82203716National Natural Science Foundation of China 82373034
6 · The paper itself

Abstract

backgroundTumor recurrence post-operation of hepatocellular carcinoma (HCC) impacts patient prognosis. Identifying and predicting 5-year HCC recurrence following surgery remains a substantial challenge.

methodsWe included 338 patients diagnosed with HCC who underwent surgery from January 2013 to December 2018. Traditional logistic regression, random forest (RF), and LASSO regression methods were used to develop a predictive model for 5-year recurrence. The findings were presented visually using nomogram. The accuracy and sensitivity of the predictive model were evaluated by receiver operating curves (ROC) and decision curve analysis (DCA).

resultsOf the 338 patients, 172 (50.9%) experienced 5 years recurrence, with a gender distribution of 79.7% males. Univariate and multivariate logistic regression analysis identified that three independent predictors of 5-year HCC recurrence (all P < 0.001). The area under the curve (AUC) value of the model (Model-1) constructed was 0.678. Then we combined LASSO regression and RF construct a predictive model including six factors: age, transarterial chemoembolization (TACE), microvascular invasion (MVI), alcohol, size, and number. The AUC of the model (Model-2) constructed was 0.733. DeLong's test results showed that Model-2 had significantly better prediction ability compared with Model-1 (P = 0.004). DCA also demonstrated that Model-2 had better predictive accuracy (P < 0.05). Then we constructed a nomogram, and Kaplan-Meier analysis showed that patients in the low-risk group had significantly better prognosis than the high (P < 0.001).

conclusionThe predictive accuracy of our model, incorporating factors, such as age, alcohol, size, number, MVI, and TACE, significantly enhances clinical practice management by accurately forecasting 5 years HCC recurrence.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsNeoplasm Recurrence, LocalAgedChemoembolization, TherapeuticFemaleHepatectomyHumansMaleMiddle AgedNomogramsPrognosisRandom ForestRetrospective StudiesRisk AssessmentRisk Factors5-year recurrenceHepatocellular carcinomaLASSONomogramRandom forest

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.